↓ Skip to main content

Cancer Immunotherapy Meets Oncology

Overview of attention for book
Cover of 'Cancer Immunotherapy Meets Oncology'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 From Basic Immunology to New Therapies for Cancer Patients
  3. Altmetric Badge
    Chapter 2 How T Cells Single Out Tumor Cells: “And That Has Made All the Difference…”
  4. Altmetric Badge
    Chapter 3 Effects of Regulatory T Cell–Dendritic Cell Interactions on Adaptive Immune Responses
  5. Altmetric Badge
    Chapter 4 Evolution of the Regulatory Landscape for Immunomodulatory Compounds and Personalized Therapeutic Cancer Vaccines
  6. Altmetric Badge
    Chapter 5 Immunoguiding, the Final Frontier in the Immunotherapy of Cancer
  7. Altmetric Badge
    Chapter 6 Developing Cancer Immunotherapies as Drugs: Setting the Stage Through Methodological Progress
  8. Altmetric Badge
    Chapter 7 Reflections on Cancer Vaccines
  9. Altmetric Badge
    Chapter 8 Dendritic Cell-Based Cancer Vaccines
  10. Altmetric Badge
    Chapter 9 mRNA Vaccination and Personalized Cancer Therapy
  11. Altmetric Badge
    Chapter 10 Antibody Therapy in Oncology
  12. Altmetric Badge
    Chapter 11 Bispecific Antibodies for the Treatment of Cancer: The Challenges of Translation
  13. Altmetric Badge
    Chapter 12 The ABCs of T Cell Receptor Gene Therapy
  14. Altmetric Badge
    Chapter 13 The Express Drivers: Chimeric Antigen Receptor-Redirected T Cells Make It to the Clinic
  15. Altmetric Badge
    Chapter 14 Immunotherapy of Malignant Melanoma
  16. Altmetric Badge
    Chapter 15 Prostate Cancer Vaccines Generated with the Disruptive RNActive® Technology Follow the Path Paved by Sipuleucel-T and Prostvac-VF
  17. Altmetric Badge
    Chapter 16 Recent Developments in the Active Immunotherapy of Renal Cell Cancer
  18. Altmetric Badge
    Chapter 17 Current Status of Immunotherapy in Gastroesophageal Cancer
  19. Altmetric Badge
    Chapter 18 Non-small Cell Lung Cancer, NSCLC
  20. Altmetric Badge
    Chapter 19 Towards More Specificity and Effectivity in the Antileukemia Immune Response
  21. Altmetric Badge
    Chapter 20 Molecular and Metabolic Cues of the Key-Lock Paradigm Dictating Immunogenic Cell Death
  22. Altmetric Badge
    Chapter 21 Pathogenesis of Minimal Residual Disease: CTCs as Novel Biomarkers in Cancer Disease
  23. Altmetric Badge
    Chapter 22 Genomics Meets Cancer Immunotherapy
  24. Altmetric Badge
    Chapter 23 Oncolytic Viruses
  25. Altmetric Badge
    Chapter 24 Final Words
Overall attention for this book and its chapters
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
61 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cancer Immunotherapy Meets Oncology
Published by
Springer International Publishing, April 2014
DOI 10.1007/978-3-319-05104-8
ISBNs
978-3-31-905103-1, 978-3-31-905104-8
Editors

Britten, Cedrik Michael, Kreiter, Sebastian, Diken, Mustafa, Rammensee, Hans-Georg

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Malaysia 1 2%
Germany 1 2%
Unknown 59 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 31%
Student > Bachelor 11 18%
Student > Ph. D. Student 10 16%
Student > Master 6 10%
Student > Postgraduate 4 7%
Other 9 15%
Unknown 2 3%
Readers by discipline Count As %
Agricultural and Biological Sciences 21 34%
Medicine and Dentistry 14 23%
Immunology and Microbiology 11 18%
Biochemistry, Genetics and Molecular Biology 6 10%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 3 5%
Unknown 3 5%